Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: The CUMAGAS-HYPERT database

American Journal of Hypertension

Volumn 23, Issue 3, 2010, Pages 305-313

  Kitsios, Georgios D ^a,b   Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptors; Adrenoceptors; Blood pressure; Database; Epidemiology; Genetic association studies; Genetic polymorphism; Hypertension; Information system; Meta analysis

Indexed keywords

ADRENERGIC RECEPTOR;

ARTICLE; DATA BASE; DATA SYNTHESIS; GENE INTERACTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HEREDITY; HUMAN; HYPERTENSION; INFORMATION SYSTEM; PRIORITY JOURNAL;

DATABASES, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; RECEPTORS, ADRENERGIC;

EID: 76749092615     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.251     Document Type: Article

References (115)

1. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7:829-840.
2. Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol 2007; 22:176-184.
3. Hamet P, Seda O. Current status of genome-wide scanning for hypertension. Curr Opin Cardiol 2007; 22:292-297.
4. Zintzaras E, Kitsios G, Kent D, Camp NJ, Atwood L, Hopkins PN, Hunt SC. Genome-wide scans meta-analysis for pulse pressure. Hypertension 2007; 50:557-564.
5. DeQuattro V, Feng M. The sympathetic nervous system: the muse of primary hypertension. J Hum Hypertens 2002; 16 Suppl 1:S64-S69.
6. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002; 415:206-212.
7. Brodde OE. β1-and β2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol 2008; 22:107-125.
8. Guimarães S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001; 53:319-356.
9. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: integrating information about genes, proteins and diseases. Trends Genet 1997; 13:163.
10. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308-311.
11. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15:7-12.
12. Finley JC Jr, O'Leary M, Wester D, MacKenzie S, Shepard N, Farrow S, Lockette W. A genetic polymorphism of the α2-adrenergic receptor increases autonomic responses to stress. J Appl Physiol 2004; 96:2231-2239.
13. Small KM, Brown KM, Forbes SL, Liggett SB. Polymorphic deletion of three intracellular acidic residues of the α2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001; 276:4917-4922.
14. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of (S1-anda2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002; 347:1135-1142.
15. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human p1-adrenergic receptor. J Biol Chem 1999; 274:12670-12674.
16. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y. The myocardium-protective Gly-49 variant of the (31-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 2002; 277:30429-30435.
17. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ. The effect of common polymorphisms of the (32-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2 1035.
18. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 5' leader cistron of the human (32-adrenergic receptor regulate receptor expression. J Clin Invest 1998; 102:1927-1932.
19. Piétri-Rouxel F, St John Manning B, Gros J, Strosberg AD. The biochemical effect of the naturally occurring Trp64-»Arg mutation on human pS3-adrenoceptor activity. Eur J Biochem 1997; 247:1174-1179
20. Sandilands AJ, O'Shaughnessy KM. The functional significance of genetic variation within the -adrenoceptor. Br J Clin Pharmacol 2005; 60:235-243.
21. Franks PW. Identifying genes for primary hypertension: methodological limitations and gene-environment interactions J Hum Hypertens 2009; 23:227-237.
22. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistica approaches. J Clin Epidemiol 2008; 61:634-645.
23. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. A navigator for human genome epidemiology. Nat Genet 2008; 40:124-125.
24. Hindorff LA, Sethupathy P Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106:9362-9367.
25. Johnson AD, O'Donnell CJ. An open access database of genome-wide association results. BMC Med Genet 2009; 10:6.
26. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap Bioinformatics 2008; 24:2938-2939.
27. Kitsios G, Zintzaras E. Genetic variation associated with ischemic heart failure a HuGE review and meta-analysis. Am J Epidemiol 2007; 166:619-633.
28. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in metaanalyses of controlled trials with binary endpoints. Stat Med 2006; 25:3443-3457.
29. Zintzaras E, Kitsios GD. Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: the CUMAGAS-CLL information system. Am J Epidemiol 2009; 170:671-678.
30. Zintzaras E, Zdoukopoulos N. A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: the CUMAGAS-PAD database. Am J Epidemiol 2009; 170:1-11.
31. Baba T, Nakajima S, Yajima Y. (33-Adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy. Horm Metab Res 1998; 30:629-632.
32. Bao X, Mills PJ, Rana BK, Dimsdale JE, Schork NJ, Smith DW, Rao F, Milic M, O'Connor DT, Ziegler MG. Interactive effects of common pS2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function. Hypertension 2005; 46:301-307.
33. Bartels NK, Börgel J, Wieczorek S, Büchner N, Hanefeld C, Bulut D, Mügge A, Rump LC, Sanner BM, Epplen JT. Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of (32-adrenergic receptor polymorphisms. BMC Med 2007; 5:1.
34. Bendlová B, Mazura I, Vcelák J, Perusicová J, Palyzová D, Klimes I, Seböková E. Is a mutation of the (33-adrenergic receptor gene related to non-insulin-dependent diabetes mellitus and juvenile hypertension in the Czech population? Ann N Y Acad Sci 1997; 827:135-143.
35. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Råstam L, Groop L Polymorphism in the p1-adrenergic receptor gene and hypertension. Circulation 2001; 104:187-190.
36. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Råstam L, Groop L|32-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 200 37:1303-1308.
37. Binder A, Garcia E, Wallace C, Gbenga K, Ben-Shlomo Y, Yarnell J, Brown P Caulfield M, Skrabal F, Kotanko P, Munroe P. Haplotypes of the (32 adrenergic receptor associate with high diastolic blood pressure in the Caerphilly prospective study J Hypertens 2006; 24:471-477.
38. Börgel J, Schulz T, Bartels NK, Epplen JT, Büchner N, Rump LC, Huesing A, Sanner BM, Mügge A. Modifying effects of the R389G (31-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea. Clin Sci 2006; 110:117-123.
39. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101:2877-2882.
40. Büettner R, Schäffler A, Arndt H, Rogler G, Nusser J, Zietz B, Enger I, Hügl S, Cuk A, Schölmerich J, Palitzsch KD. The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998; 83: 2892-2897.
41. Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, Cockcroft J, Hall I P. Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 2000; 18:167-172.
42. Castellano M, Rossi F, Giacchè M, Perani C, Rivadossi F, Muiesan ML, Salvetti M, Beschi M, Rizzoni D, Agabiti-Rosei E. β2-Adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 2003; 41:361-367.
43. Etzel J P, Rana BK, Wen G, Parmer RJ, Schork NJ, O'Connor DT, Insel PA. Genetic variation at the human α2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension 2005; 45:1207-1213.
44. Filigheddu F, Reid JE, Troffa C, PinnaParpaglia P, Argiolas G, Testa A, Skolnick M, Glorioso N. Genetic polymorphisms of the β-adrenergic system: association with essential hypertension and response to β-blockade. Pharmacogenomics J 2004; 4:154-160.
45. Fossum E, Berge KE, Høieggen A, Moan A, Rostrup M, Kjeldsen SE, Eide I, Berg K. Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure. Blood Press 2001; 10:92-100.
46. Freitas SR, Pereira AC, Floriano MS, Mill JG, Krieger JE. Association of α1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population. BMC Cardiovasc Disord 2008; 8:40.
47. Fujisawa T, Ikegami H, Yamato E, Hamada Y, Kamide K, Rakugi H, Higaki J, Murakami H, Shimamoto K, Ogihara T. Trp64Arg mutation of β3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am J Hypertens 1997; 10:101-105.
48. Galletti F, Iacone R, Ragone E, Russo O, Della Valle E, Siani A, Barba G, Farinaro E, Strazzullo V, Strazzullo P. Lack of association between polymorphism in the β2-adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study. Am J Hypertens 2004; 17:718-720.
49. Ge D, Huang J, He J, Li B, Duan X, Chen R, Gu D. β2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese. Ann Hum Genet 2005; 69:36-44.
50. Gjesing A P, Andersen G, Albrechtsen A, Glümer C, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O. Studies of associations between the Arg389Gly polymorphism of the β1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabet Med 2007; 24:392-397.
51. Gjesing A P, Andersen G, Burgdorf KS, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O. Studies of the associations between functional β2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia 2007; 50:563-568. (Pubitemid 46215499)
52. Gu D, Su S, Ge D, Chen S, Huang J, Li B, Chen R, Qiang B. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006; 47:1147-1154. (Pubitemid 44289172)
53. Hassan M, York KM, Li H, Li Q, Gong Y, Langaee T Y, Fillingim RB, Johnson JA, Sheps DS. Association of β1-adrenergic receptor genetic polymorphism with mental stress-induced myocardial ischemia in patients with coronary artery disease. Arch Intern Med 2008; 168:763-770.
54. Heckbert SR, Hindorff LA, Edwards KL, Psaty BM, Lumley T, Siscovick DS, Tang Z, Durda J P, Kronmal RA, Tracy R P. β2-Adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003; 107: 2021-2024.
55. Herrmann SM, Nicaud V, Tiret L, Evans A, Kee F, Ruidavets JB, Arveiler D, Luc G, Morrison C, Hoehe MR, Paul M, Cambien F. Polymorphisms of the β2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 2002; 20:229-235.
56. Herrmann V, Büscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. Am J Hypertens 2000; 13:1021-1026.
57. Hui P, Nakayama T, Morita A, Sato N, Hishiki M, Saito K, Yoshikawa Y, Tamura M, Sato I, Takahashi T, Soma M, Izumi Y, Ozawa Y, Cheng Z. Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens Res 2007; 30:585-592.
58. Jia H, Sharma P, Hopper R, Dickerson C, Lloyd DD, Brown MJ. β2-Adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians. J Hypertens 2000; 18:687-693.
59. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y. Association analysis of β2-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 2001; 37:286-292.
60. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJ, Skrabal F, Caulfield M. Essential hypertension in African Caribbeans associates with a variant of the β2-adrenoceptor. Hypertension 1997; 30:773-776.
61. Lee YW, Oh VM, Garcia E, Taylor EA, Wu H, Yap E P, Kazeem GR, Caulfield MJ, Munroe PB. Haplotypes of the β2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population. J Hypertens 2004; 22:2111-2116.
62. Li JL, Canham RM, Vongpatanasin W, Leonard D, Auchus RJ, Victor RG. Do allelic variants in α2A and α2C adrenergic receptors predispose to hypertension in blacks? Hypertension 2006; 47:1140-1146.
63. Lin RCY, Ericsson JO, Benjafield AV, Morris BJ. Association of β2-adrenoceptor Gln27Glu variant with body weight but not hypertension. Am J Hypertens 2001; 14:1201-1204.
64. Lockette W, Ghosh S, Farrow S, MacKenzie S, Baker S, Miles P, Schork A, Cadaret L. α2-Adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens 1995; 8:390-394.
65. Misono M, Maeda S, Iemitsu M, Nakata Y, Otsuki T, Sugawara J, Zempo H, Yoshizawa M, Miyaki A, Kuno S, Matsuda M, Ajisaka R. Combination of polymorphisms in the β2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension. J Hypertens 2009; 27: 1377-1383.
66. Mo W, Zhang GG, Yang TL, Dai X P, Li HH, Zeng H, Liu J, Tan YM, Zhou HH, Liu ZQ. The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients. Clin Chem Lab Med 2007; 45:493-498.
67. Morris BJ, Zee RY, Ying LH, Griffiths LR. Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-I genes with essential hypertension. Clin Sci 1993; 85:189-195.
68. Nagano T, Matsuda Y, Tanioka T, Yoshioka T, Hiroi T, Yoshikawa K, Okabe K, Osaka K, Nagamine I, Takasaka Y. No association of the Trp 64 Arg mutation of the β3-adrenergic receptor gene with obesity, type 2 diabetes mellitus, hyperlipidemia, and hypertension in Japanese patients with schizophrenia. J Med Invest 2005; 52:57-64.
69. Nieminen T, Lehtimäki T, Laiho J, Rontu R, Niemelä K, Kööbi T, Lehtinen R, Viik J, Turjanmaa V, Kähönen M. Effects of polymorphisms in β1-adrenoceptor and α-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study. J Appl Physiol 2006; 100: 507-511.
70. Oeveren van-Dybicz AM, Vonkeman HE, Bon MA, van den Bergh FA, Vermes I. β3-Adrenergic receptor gene polymorphism and type 2 diabetes in a Caucasian population. Diabetes Obes Metab 2001; 3:47-51.
71. Ohlin B, Berglund G, Nilsson PM, Melander O. Job strain, decision latitude and α2B-adrenergic receptor polymorphism significantly interact, and associate with higher blood pressures in men. J Hypertens 2007; 25: 1613-1619.
72. Pereira AC, Floriano MS, Mota G F, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE. β2 Adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 2003; 42: 685-692.
73. Piérola J, Barceló A, de la Peña M, Barbé F, Soriano JB, Sánchez Armengol A, Martínez C, Agustí A. β3-Adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur Respir J 2007; 30:743-747.
74. Pojoga L, Kolatkar NS, Williams JS, Perlstein TS, Jeunemaitre X, Brown NJ, Hopkins PN, Raby BA, Williams GH. β2 Adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension 2006; 48: 892-900.
75. Porto PI, García SI, Dieuzeide G, González C, Landa MS, Pirola CJ. Clinical features of the metabolic syndrome in adolescents: minor role of the Trp64Arg β3-adrenergic receptor gene variant. Pediatr Res 2004; 55:836-841.
76. Ranade K, Shue WH, Hung YJ, Hsuing CA, Chiang FT, Pesich R, Hebert J, Olivier M, Chen YD, Pratt R, Olshen R, Curb D, Botstein D, Risch N, Cox DR. The glycine allele of a glycine/arginine polymorphism in the β2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin. Am J Hypertens 2001; 14:1196-1200.
77. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N. A polymorphism in the β1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70:935-942.
78. Ringel J, Kreutz R, Distler A, Sharma AM. The Trp64Arg polymorphism of the β3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. Am J Hypertens 2000; 13:1027-1031.
79. Ruixing Y, Jinzhen W, Shangling P, Weixiong L, Dezhai Y, Yuming C. Sex differences in environmental and genetic factors for hypertension. Am J Med 2008; 121:811-819.
80. Sethi AA, Tybjaerg-Hansen A, Jensen GB, Nordestgaard BG. 164Ile allele in the β2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study. Pharmacogenet Genomics 2005; 15:633-645.
81. Shioji K, Kokubo Y, Mannami T, Inamoto N, Morisaki H, Mino Y, Tagoi N, Yasui N, Iwaii N. Association between hypertension and the α-adducin, β1-adrenoreceptor, and G-protein β3 subunit genes in the Japanese population; the Suita study. Hypertens Res 2004; 27:31-37.
82. Snapir A, Heinonen P, Tuomainen T P, Alhopuro P, Karvonen MK, Lakka TA, Nyyssönen K, Salonen R, Kauhanen J, Valkonen V P, Pesonen U, Koulu M, Scheinin M, Salonen JT. An insertion/deletion polymorphism in the α2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 2001; 37:1516-1522.
83. Strazzullo P, Iacone R, Siani A, Cappuccio F P, Russo O, Barba G, Barbato A, D'Elia L, Trevisan M, Farinaro E. Relationship of the Trp64Arg polymorphism of the β3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 2001; 19:399-406.
84. Sun L, Schulte N, Pettinger P, Regan JW, Pettinger WA. The frequency of α2-adrenoceptor restriction fragment length polymorphisms in normotensive and hypertensive humans. J Hypertens 1992; 10:1011-1015.
85. Sunder-Plassmann G, Kittler H, Eberle C, Hirschl MM, Woisetschläger C, Derhaschnig U, Laggner AN, Hörl WH, Födinger M. Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med 2002; 30:2236-2241.
86. Svetkey L P, Timmons PZ, Emovon O, Anderson NB, Preis L, Chen YT. Association of hypertension with β2-and α2c10-adrenergic receptor genotype. Hypertension 1996; 27:1210-1215.
87. Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T, Tsujita Y, Horie M, Miki T, Ueshima H. Relationship between metabolic syndrome and Trp64arg polymorphism of the β-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertens Res 2006; 29:891-896.
88. Tang W, Devereux RB, Kitzman DW, Province MA, Leppert M, Oberman A, Hopkins PN, Arnett DK. The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function. Am J Hypertens 2003; 16:945-951.
89. Thomas GN, Tomlinson B, Chan JC, Young R P, Critchley JA. The Trp64Arg polymorphism of the β3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 2000; 24:545-551. (Pubitemid 30323484)
90. Tonolo G, Melis MG, Secchi G, Atzeni MM, Angius MF, Carboni A, Ciccarese M, Malavasi A, Maioli M. Association of Trp64Arg β3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens 1999; 17:33-38.
91. Umemura S, Hirawa N, Iwamoto T, Yamaguchi S, Toya Y, Kobayashi S, Takasaki I, Yasuda G, Tamura K, Ishii M. Association analysis of restriction fragment length polymorphism for α2-adrenergic receptor genes in essential hypertension in Japan. Hypertension 1994; 23:I203-I206.
92. Vasudevan R, Ismail P, Stanslas J, Shamsudin N, Ali AB. Association of insertion/ deletion polymorphism of α-adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in Malaysian subjects. Int J Biol Sci 2008; 4:362-367.
93. Von Wowern F, Bengtsson K, Lindblad U, Råstam L, Melander O. Functional variant in the α2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension 2004; 43:592-597.
94. Wu H, Tang W, Li H, Zhou X, Yang Y, Yu H, Li K, Xiao C, Deng AY. Association of the β2-adrenergic receptor gene with essential hypertension in the non-Han Chinese Yi minority human population. J Hypertens 2006; 24:1041-1047. (Pubitemid 43772311)
95. Xie HG, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, Brown NJ, Goree RE, Haines JL, Wood AJ. Human β2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther 2000; 67:670-675.
96. Yamada Y, Ando F, Shimokata H. Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals. Int J Mol Med 2007; 19:675-683.
97. Yu SF, Zhou WH, Jiang KY, Gu GZ, Wang S. Job stress, gene polymorphism of β2-AR, and prevalence of hypertension. Biomed Environ Sci 2008; 21:239-246.
98. Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML. T64A polymorphism in β3-adrenergic receptor gene (ADRB3) and coronary heart disease: a case-cohort study and meta-analysis. J Intern Med 2008; 263:79-89.
99. Zak I, Sarecka-Hujar B, Krauze J. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of β2-adrenergic receptor gene, and the risk of coronary artery disease. Kardiol Pol 2008; 66:380-386; discussion 387.
100. Yang HC, Liang YJ, Wu YL, Chung CM, Chiang KM, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Leu HB, Yin WH, Chiu T Y, Chen CI, Fann CS, Wu JY, Lin TN, Lin SJ, Chen YT, Chen JW, Pan WH. Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS ONE 2009; 4:e5459.
101. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, Aulchenko Y, Lumley T, Köttgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, Arking DE, Mitchell GF, Mattace-Raso FU, Smith AV, Taylor K, Scharpf RB, Hwang SJ, Sijbrands EJ, Bis J, Harris TB, Ganesh SK, O'Donnell CJ, Hofman A, Rotter JI, Coresh J, Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JC, Boerwinkle E, Wang TJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, van Duijn CM. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; e-pub ahead of print 10 May 2009.
102. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, Zhou J, Lashley K, Chen Y, Christman M, Rotimi C. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5:e1000564.
103. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
104. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, Shi X, Pan L, Rampersaud E, Shen H, Kim JD, Subramanya AR, Steinle NI, Parsa A, Ober CC, Welling PA, Chakravarti A, Weder AB, Cooper RS, Mitchell BD, Shuldiner AR, Chang Y P. From the Cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106: 226-231.
105. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, Veldre G, Döring A, Viigimaa M, Sõber S, Tomberg K, Eckstein G, Kelgo P, Rebane T, Shaw-Hawkins S, Howard P, Onipinla A, Dobson RJ, Newhouse SJ, Brown M, Dominiczak A, Connell J, Samani N, Farrall M, Caulfield MJ, Munroe PB, Illig T, Wichmann HE, Meitinger T, Laan M. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet 2009; 18:2288-2296.
106. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight B F, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, Kuusisto J, Burton PR, Hadley D, McArdle WL, Brown M, Dominiczak A, Newhouse SJ, Samani NJ, Webster J, Zeggini E, Beckmann JS, Bergmann S, Lim N, Song K, Vollenweider P, Waeber G, Waterworth DM, Yuan X, Groop L, Orho-Melander M, Allione A, Di Gregorio A, Guarrera S, Panico S, Ricceri F, Romanazzi V, Sacerdote C, Vineis P, Barroso I, Sandhu MS, Luben RN, Crawford GJ, Jousilahti P, Perola M, Boehnke M, Bonnycastle LL, Collins FS, Jackson AU, Mohlke KL, Stringham HM, Valle TT, Willer CJ, Bergman RN, Morken MA, Döring A, Gieger C, Illig T, Meitinger T, Org E, Pfeufer A, Wichmann HE, Kathiresan S, Marrugat J, O'Donnell CJ, Schwartz SM, Siscovick DS, Subirana I, Freimer NB, Hartikainen AL, McCarthy MI, O'Reilly PF, Peltonen L, Pouta A, de Jong PE, Snieder H, van Gilst WH, Clarke R, Goel A, Hamsten A, Peden JF, Seedorf U, Syvänen AC, Tognoni G, Lakatta EG, Sanna S, Scheet P, Schlessinger D, Scuteri A, Dörr M, Ernst F, Felix SB, Homuth G, Lorbeer R, Reffelmann T, Rettig R, Völker U, Galan P, Gut IG, Hercberg S, Lathrop GM, Zelenika D, Deloukas P, Soranzo N, Williams FM, Zhai G, Salomaa V, Laakso M, Elosua R, Forouhi NG, Völzke H, Uiterwaal CS, van der Schouw YT, Numans ME, Matullo G, Navis G, Berglund G, Bingham SA, Kooner JS, Connell JM, Bandinelli S, Ferrucci L, Watkins H, Spector TD, Tuomilehto J, Altshuler D, Strachan D P, Laan M, Meneton P, Wareham NJ, Uda M, Jarvelin MR, Mooser V, Melander O, Loos RJ, Elliott P, Abecasis GR, Caulfield M, Munroe PB. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; e-pub ahead of print 10 May 2009.
107. Saxena R, Voight B F, Lyssenko V, Burtt N P, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Boström K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Råstam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjögren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316:1331-1336.
108. Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009; 360:1696-1698.
109. Cheung KH, Osier MV, Kidd JR, Pakstis AJ, Miller PL, Kidd KK. ALFRED: an allele frequency database for diverse populations and DNA polymorphisms. Nucleic Acids Res 2000; 28:361-363.
110. Yu W, Wulf A, Liu T, Khoury MJ, Gwinn M. Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics 2008; 9:528.
111. Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 2008; 10:560-574.
112. Kitsios GD, Zintzaras E. Genome-wide association studies: hypothesis-"free" or "engaged"? Transl Res 2009; 154:161-164.
113. Kraft P, Raychaudhuri S. Complex diseases, complex genes: keeping pathways on the right track. Epidemiology 2009; 20:508-511.
114. Zintzaras E, Kitsios G, Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 2006; 48: 700-710.
115. Zintzaras E, Kitsios G, Stefanidis I. Response to endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis. Hypertension 2007; 49:E2.